Pancreatic Cancer Research

ResearcherYokohama City University HospitalActive in the last 2 years

Yoshimasa Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-7948-5332; OpenAlex author ID A5006544074. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of TP53 status in gemcitabine plus nab-paclit… Co-author DOI 10.1016/j.esmogo.2025.100221↗
  2. Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity. Co-author DOI 10.1038/s41598-024-68061-y↗
  3. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy. Co-author DOI 10.1111/cas.14245↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Sugimori · 3 shared papers, 2020–2025 · strength 0.47
  2. Shin Maeda · 3 shared papers, 2020–2025 · strength 0.47
  3. Masanori Oshi · 1 shared paper, 2025 · strength 0.21
  4. Manabu Morimoto · 1 shared paper, 2025 · strength 0.21
  5. Hajime Yamazaki · 1 shared paper, 2025 · strength 0.21
  6. Yuichiro Tozuka · 1 shared paper, 2020 · strength 0.08
  7. Takashi Kaneko · 1 shared paper, 2020 · strength 0.08
  8. Masatsugu Nagahama · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.